Humacyte HUMA
NASDAQ HUMA
$0.51 -0.01 (-1.74%)
As of: Oct 1, 2026 · 11:46 AM EDT

Humacyte (HUMA) Long-Term Investments (2020 - 2021)

Updated

Humacyte's Long-Term Investments came in at $100.03 million for Q2 2021, unchanged from the prior quarter.

Analysis

Humacyte (HUMA) Long-Term Investments (2020 - 2021) Analysis & Trends

At the end of FY2020, Humacyte's Long-Term Investments was $100.02 million.

  • Business Quant data shows HUMA's Long-Term Investments at $100.03 million (Q1 2021), $100.02 million (Q4 2020) and $99.98 million (Q3 2020) in the three quarters before Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 266.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.62 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.79 Bn
10 Humacyte 144.46 Mn 144.46 Mn -825,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 100.03 Mn
Mar 31, 2021 100.03 Mn
Dec 31, 2020 100.02 Mn
Sep 30, 2020 99.98 Mn
API Access

Humacyte Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=HUMA&period=max&api_key=YOUR_API_KEY